Mu-opioid receptor expression on B cells as a potential biomarker for chronic pain: a follow-up study with patients with fibromyalgia
Abstract. Introduction:. Before COVID-19 pandemic, we identified the percentage of B cells expressing the Mu-opioid receptor (Mu+ B cells) as a potential marker, named Mu-Lympho-Marker (MLM), for chronic pain (CP) in patients with fibromyalgia (FM) and osteoarthritis. Objectives:. Here, we demonstra...
Saved in:
| Main Authors: | Valentina Malafoglia, William Raffaeli, Sara Ilari, Chiara Gioia, Cristina Iannuccelli, Michael Tenti, Laura Vitiello, Stefania Proietti, Leonardo Lupacchini, Lucia Carmela Passacatini, Carlo Tomino, Mollace Vincenzo, Massimo Fini, Manuela Di Franco, Carolina Muscoli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-08-01
|
| Series: | PAIN Reports |
| Online Access: | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000001283 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
by: Raphael Rozenfeld, et al.
Published: (2007-01-01) -
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System
by: Mario García-Domínguez
Published: (2025-01-01) -
Сentral and peripheral mechanisms of mu-opioid analgesia and tolerance
by: Yu. A. Kolesnikov
Published: (2020-03-01) -
Presynaptic control of nociceptor signalling: Differential influence of Mu Opioid and GABAergic Systems
by: Ruth C Riley, et al.
Published: (2000-01-01) -
Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.
by: Vladana Vukojević, et al.
Published: (2008-01-01)